Published in Cancer Weekly, March 16th, 2004
"Several patient and tumor factors go into the decision process to determine whether a breast cancer patient is a good candidate for breast-conserving therapy. The patient must be seen by all disciplines before any therapeutic intervention," researchers in the United States report.
"When used appropriately, breast-conserving therapy produces maximal disease control and improves quality of life in patients with early-stage breast cancer," wrote Rashmi K. Benda and colleagues at the University of Florida.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.